Area of research
Pharmacology · Experimental and Cognitive Psychology
Research interest
Research interests include Medicine, Psychology, Ketamine, Treatment-resistant depression, Major depressive disorder, and Depression (economics).
Molecular Transducers of Physical Activity Consortium (MoTrPAC): human studies design and protocol
Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression
Very Low-Level Transcranial Photobiomodulation for Major Depressive Disorder
Peripheral immune cell reactivity and neural response to reward in patients with depression and anhedonia
Interoception and Obsessive-Compulsive Disorder: A Review of Current Evidence and Future Directions
Affective and somatic symptom clusters in depression and their relationship to treatment outcomes in the STAR*D sample
Dimensions of interoception in obsessive-compulsive disorder
Lithium continuation therapy following ketamine in patients with treatment resistant unipolar depression: a randomized controlled trial
Initial Evidence for Brain Plasticity Following a Digital Therapeutic Intervention for Depression
Effects of the KCNQ channel opener ezogabine on functional connectivity of the ventral striatum and clinical symptoms in patients with major depressive disorder
ELEctroconvulsive therapy (ECT) vs. Ketamine in patients with Treatment-resistant Depression: The ELEKT-D study protocol
A pilot study of minocycline for the treatment of bipolar depression: Effects on cortical glutathione and oxidative stress in vivo
A randomized, controlled pilot trial of the Emotional Faces Memory Task: a digital therapeutic for depression
A Randomized Dose-Ranging Study of Neuropeptide Y in Patients with Posttraumatic Stress Disorder
Dextromethorphan/quinidine pharmacotherapy in patients with treatment resistant depression: A proof of concept clinical trial
Ketamine Treatment and Global Brain Connectivity in Major Depression
Reduced global functional connectivity of the medial prefrontal cortex in major depressive disorder
Using Placebo Response to Pain as a Predictor of Placebo Response in Mood Disorders
Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial
Neurocognitive effects of ketamine in treatment-resistant major depression: association with antidepressant response
Non-cancer life stressors contribute to impaired quality of life in ovarian cancer patients
Paraneoplastic Thrombocytosis in Ovarian Cancer
Rapid and Longer-Term Antidepressant Effects of Repeated Ketamine Infusions in Treatment-Resistant Major Depression